prison

This webinar focuses on: Overcoming organisational and cultural issues Stabilisation and assisted withdrawal Retox and continuity of care Presenters: Dr Joss Bray, Clinical Lead for Drug and Alcohol Treatment in the North East Prisons for...

Time to consolidate the lessons of the last five instalments of our course on drug treatment research. Row 5 explored key studies on treatment in relation to safeguarding the family and the community from crime. A common theme was the...

Mombasa's prison department will soon be introducing methadone programs for heroin injecting drug users.

Last of the 25 cells of the Drug Treatment Matrix explores research on how local treatment systems can protect the community – treatment in itself, and treatment offered or imposed by law enforcement authorities. The task is to meld...

Key studies on the contribution of the practitioner to reducing crime and safeguarding the community. Commentary risks formulating a general rule: The trickier the situation, the more the worker matters. Implication is that therapeutic...

Opinion is sharply divided on the ethics and effectiveness of pressuring opioid-dependent offenders to take the opiate-blocker naltrexone. Especially sharp is the controversy over long-acting products not approved for medical use in the UK...

Key studies on treatment’s contribution to safeguarding the community and preventing crime. Commentary addresses two highly controversial issues: whether it is ever safe to leave children with seriously problematic drug users, and the...

Effectiveness Bank Analysis: Keep Maintaining Opiate-Dependent Prisoners From the USA, a rare randomised trial found in favour of continuing methadone maintenance when patients entered prison rather than compulsory withdrawal. The potential...